Skip to search formSkip to main contentSkip to account menu

Amyloidosis

Known as: Amyloidosis NOS, AMYLOID, amyloid diseases 
A group of diseases in which protein builds up in certain organs (localized amyloidosis) or throughout the body (systemic amyloidosis). Amyloidosis… 
National Institutes of Health

Related topics

Related topics

48 relations
2 ML Digoxin 0.25 MG/ML InjectionAcetylcysteineAcetylcysteine 200 MG/ML Inhalant SolutionAmyloid

Narrower (14)

AMYLOIDOSIS, HEREDITARY, CARDIOPATHICAMYLOIDOSIS, SECONDARY GENERALIZEDAmyloid Neuropathies, FamilialAmyloidosis, Primary Cutaneous

Broader (2)

Inborn Errors of MetabolismMetabolic Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Safety and efficacy of RNAi therapy for transthyretin amyloidosis.
BACKGROUND Transthyretin amyloidosis is caused by the deposition of hepatocyte-derived transthyretin amyloid in peripheral nerves… 
Highly Cited
2010
Highly Cited
2010
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Highly Cited
2007
Highly Cited
2007
Natural history and outcome in systemic AA amyloidosis.
BACKGROUND Deposition of amyloid fibrils derived from circulating acute-phase reactant serum amyloid A protein (SAA) causes… 
Review
2006
Review
2006
Protein misfolding, functional amyloid, and human disease.
Peptides or proteins convert under some conditions from their soluble forms into highly ordered fibrillar aggregates. Such… 
Highly Cited
2006
Highly Cited
2006
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
We have generated a novel transgenic mouse model on a C57BL/6J genetic background that coexpresses KM670/671NL mutated amyloid… 
Review
2005
Review
2005
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
We undertook this study to develop uniformly accepted criteria for the definition of organ involvement and response for patients… 
Review
2003
Review
2003
Molecular mechanisms of amyloidosis.
Amyloidosis affects millions of people, as a cause of Alzheimer's disease or a complication of dialysis, and also causes rare… 
Highly Cited
1994
Highly Cited
1994
Advanced glycation end products contribute to amyloidosis in Alzheimer disease.
Alzheimer disease (AD) is characterized by deposits of an aggregated 42-amino-acid beta-amyloid peptide (beta AP) in the brain… 
Review
1993
Review
1993
Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
Review
1980
Review
1980
Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).
  • G. Glenner
  • The New England journal of medicine
  • 1980
  • Corpus ID: 9485901
SINCE Cohen's review of amyloidosis was published in the Journal in 1967, there have been major advances in our understanding of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License